{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:27:55Z","timestamp":1787862475594,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200026"],"award-info":[{"award-number":["451-03-136\/2025-03\/200026"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200168"],"award-info":[{"award-number":["451-03-136\/2025-03\/200168"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-136\/2025-03\/200007"],"award-info":[{"award-number":["451-03-136\/2025-03\/200007"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["256716"],"award-info":[{"award-number":["256716"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016047","name":"Science Fund of the Republic of Serbia","doi-asserted-by":"publisher","award":["7005"],"award-info":[{"award-number":["7005"]}],"id":[{"id":"10.13039\/501100016047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108967","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:00:29Z","timestamp":1757347229000},"page":"108967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells"],"prefix":"10.1016","volume":"165","author":[{"given":"Pavle","family":"Stojkovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Lup\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a Terzi\u0107","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Stepanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskev","family":"Nedialkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Podolski-Reni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Pe\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor M.","family":"Opsenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108967_bb0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108967_bb0010","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1021\/acs.jmedchem.9b00246","article-title":"Fixing the unfixable: the art of optimizing natural products for human medicine","volume":"62","author":"Y\u00f1igez-Gutierrez","year":"2019","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108967_bb0015","article-title":"The bioactivities of sclareol: a mini review","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108967_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0145-2126(98)00134-9","article-title":"The effect of sclareol on growth and cell cycle progression of human leukemic cell lines","volume":"23","author":"Dimas","year":"1999","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bioorg.2025.108967_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10495-006-0026-8","article-title":"Sclareol induces apoptosis in human HCT116 colon cancer cells in vitro and suppression of HCT116 tumor growth in immunodeficient mice","volume":"12","author":"Dimas","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2025.108967_bb0030","first-page":"6795","article-title":"Modulation of anoikis resistance in MG63 osteosarcoma cells by sclareol via inhibiting ezrin\/Fak expression","volume":"9","author":"Mo","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2025.108967_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biopha.2006.01.003","article-title":"Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs","volume":"60","author":"Dimas","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108967_bb0040","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.3892\/mmr.2017.6480","article-title":"Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bioorg.2025.108967_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116496","article-title":"Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma","volume":"174","author":"Stepanovi\u0107","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108967_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106605","article-title":"Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells","volume":"138","author":"Stojkovi\u0107","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108967_bb0055","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/cr100264t","article-title":"The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives","volume":"113","author":"Wanka","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108967_bb0060","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2174\/092986710792065027","article-title":"Use of the adamantane structure in medicinal chemistry","volume":"17","author":"Lamoureux","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108967_bb0065","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.ejmech.2011.01.047","article-title":"The many faces of the adamantyl group in drug design","volume":"46","author":"Liu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108967_bb0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1021\/jm00329a007","article-title":"The adamantyl group in medicinal agents. II. Anabolic steroid 17-beta-adamantoates","volume":"8","author":"Rapala","year":"1965","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108967_bb0075","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2003-02-0562","article-title":"Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells","volume":"102","author":"Chandra","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2025.108967_bb0080","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1158\/1078-0432.CCR-05-0291","article-title":"Transcriptional profiling identifies altered intracellular labile iron homeostasis as a contributing factor to the toxicity of adaphostin: decreased vascular endothelial growth factor secretion is independent of hypoxia-inducible factor-1 regulation","volume":"11","author":"Hose","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108967_bb0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/CAD.0000000000000511","article-title":"Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models","volume":"28","author":"Aouad","year":"2017","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bioorg.2025.108967_bb0090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10637-011-9689-2","article-title":"Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models","volume":"30","author":"Di Francesco","year":"2011","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bioorg.2025.108967_bb0095","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.29407","article-title":"ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model","volume":"137","author":"Nasr","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108967_bb0100","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1158\/1078-0432.CCR-16-2363","article-title":"A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors","volume":"23","author":"Britten","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108967_bb0105","article-title":"Characterization of isoenzyme-selective inhibitors of human sphingosine kinases","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108967_bb0110","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2147\/DDDT.S367612","article-title":"Recent progress in the development of opaganib for the treatment of COVID-19","volume":"16","author":"Smith","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2025.108967_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acsmedchemlett.8b00053","article-title":"Novel aminoquinoline derivatives significantly reduce parasite load in leishmania infantum infected mice","volume":"9","author":"Konstantinovi\u0107","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108967_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128167","article-title":"Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway","volume":"46","author":"Rastelli","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108967_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104794","article-title":"Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR","volume":"110","author":"Wassel","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108967_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115041","article-title":"Natural carrier-free self-assembled diterpene nanoparticles with its efficient anti-inflammation through the inhibition of NF-\u03baB pathway for accelerated wound healing","volume":"165","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108967_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40005-020-00504-w","article-title":"Physical properties of nanoparticles do matter","volume":"51","author":"Kiio","year":"2021","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.bioorg.2025.108967_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/molecules22020297","article-title":"Adamantane in drug delivery systems and surface recognition","volume":"22","author":"\u0160timac","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108967_bb0145","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/jm8013822","article-title":"Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar","volume":"52","author":"K\u00fchnle","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108967_bb0150","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.febslet.2005.12.060","article-title":"The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research","volume":"580","author":"Gottesman","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2025.108967_bb0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1039\/C1MD00022E","article-title":"Ester prodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies","volume":"2","author":"Dubar","year":"2011","journal-title":"Med. Chem. Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:58:54Z","timestamp":1777463934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"alternative-id":["S0045206825008478"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108967","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108967"}}